Sunday, November 15, 2026 · Agents

From Issue 103 (2026-11-15) · 17 stories in this issue

06 VC

❯ Mirendil raises a $1 billion Series A while its research-agent platform Lor remains in private beta

Capital backs a research platformMirendil announced a $1 billion Series A on November 12, led by Kleiner Perkins and Clearlake Capital, with Google, Battery Ventures and others participating. It did not disclose a valuation. The core product direction is to let researchers organize AI development through agents that connect coding, compute provisioning, experiments and analysis. The financing supports continued platform development, without a published breakdown of spending allocations.

Researchers decide and agents executeThe company introduced Lor on October 28. It can distribute work across dozens or hundreds of agents, provision compute nodes and release resources when tasks finish. A researcher might delegate overnight ablation experiments and ask for a report rather than continuously supervise the training jobs. People still decide what to try and which results to trust. Lor supports third-party and Mirendil models, targeting research and engineering teams running extended experiments.

Internal research precedes customer validationIn the weeks before the financing, Mirendil published initial model and product results. The company says one researcher working with agents pretrained Mirendil-Base in three and a half months for less than $10 million of compute, then post-trained it into the long-context model Fern. These are company-reported demonstrations of its internal workflow. They do not constitute measured results from broad external customer adoption.

Commercialization remains earlyLor is invitation-only, free during its private beta, and available on macOS, Linux and the web; other platforms remain planned. Funding enables continued research and product work, but public materials give no date for paid availability or general release and disclose no customer revenue. The product has reached external testing. Establishing a mature, paid research-software business remains a subsequent commercialization task.

▮ SIGNALMirendil combines models, experiment execution and compute orchestration in one research workflow; expanding the research capacity of small teams depends on private-beta validation of reliable, long-running experiments.